Richard Auchus, MD, PhD, discusses how crinecerfont is improving CAH care and easing the transition from pediatric to adult management.
Richard Auchus, MD, PhD
Advertisement
Richard Auchus, MD, PhD, professor of pharmacology and internal medicine, University of Michigan.
Articles by Richard Auchus, MD, PhD
Richard Auchus, MD, PhD, highlights data showing that crinecerfont use in children with CAH can improve metabolic outcomes.
Advertisement
Latest Updated Articles
Richard Auchus, MD, on how crinecerfont is changing CAH treatmentPublished: August 14th 2025 | Updated:
Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAHPublished: July 31st 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
GeneDx receives FDA Breakthrough Device Designation for whole genome and exome tests
2
How well do you know the latest genetic testing guidelines?
3
Tapinarof Efficacy and Safety in Pediatric AD Care
4
FDA, CDC investigating multistate infant botulism outbreak tied to formula
5
